Concordare Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

Concordare General Information

Description

Developer of clinical trial protocol digitization software designed to standardize and operationalize study documents. The company's platform offers artificial intelligence-based protocol conversion, automated generation of study tools, and system integration features, enabling clinical research sites and sponsors to manage trials from a single digital protocol source.

Contact Information

Website
www.concordare.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 606 West 42nd Street
  • 405
  • New York, NY 10168
  • United States
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 606 West 42nd Street
  • 405
  • New York, NY 10168
  • United States

Concordare Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Concordare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 25-Aug-2026 Completed Generating Revenue
4. Accelerator/Incubator 09-Mar-2026 Completed Generating Revenue
3. Seed Round 04-Mar-2026 Completed Generating Revenue
2. Accelerator/Incubator 20-Jan-2026 $100K $100K Completed Generating Revenue
1. Accelerator/Incubator 09-May-2024 Completed Generating Revenue
To view Concordare’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Concordare Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Concordare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260310656-A1 Systems and methods for database management with constrained artificial intelligence Pending 04-Apr-2025
US-20260310682-A1 Systems and methods for database management with constrained artificial intelligence Pending 04-Apr-2025
WO-2026213524-A1 Systems and methods for database management with constrained artificial intelligence Pending 04-Apr-2025 G06F16/2386

Concordare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Concordare Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gaingels Venture Capital Minority
Techstars Accelerator/Incubator Minority
Surface Ventures Venture Capital Minority
AlphaLab Accelerator/Incubator Minority
Innovation Works Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Concordare FAQs

  • When was Concordare founded?

    Concordare was founded in 2024.

  • Where is Concordare headquartered?

    Concordare is headquartered in New York, NY.

  • What is the size of Concordare?

    Concordare has 7 total employees.

  • What industry is Concordare in?

    Concordare’s primary industry is Enterprise Systems (Healthcare).

  • Is Concordare a private or public company?

    Concordare is a Private company.

  • What is Concordare’s current revenue?

    The current revenue for Concordare is .

  • How much funding has Concordare raised over time?

    Concordare has raised $1.62M.

  • Who are Concordare’s investors?

    Gaingels, Techstars, Surface Ventures, AlphaLab, and Innovation Works are 5 of 6 investors who have invested in Concordare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process